WallStreetZenWallStreetZen

NYSE: ALUR
Allurion Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ALUR

Based on 1 analyst offering 12 month price targets for Allurion Technologies Inc

Min Forecast
$2.50+35.14%
Avg Forecast
$2.50+35.14%
Max Forecast
$2.50+35.14%

Should I buy or sell ALUR stock?

Based on 1 analyst offering ratings for Allurion Technologies Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALUR stock forecasts and price targets.

ALUR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-20

1 of 1

Forecast return on equity

Is ALUR forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is ALUR forecast to generate an efficient return on assets?

Company
-64.74%
Industry
11.68%
ALUR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALUR earnings per share forecast

What is ALUR's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.35
Avg 2 year Forecast
-$1.27

ALUR revenue forecast

What is ALUR's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$17.1M-0.35%
Avg 2 year Forecast
$24.4M+41.6%
ALUR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALUR revenue growth forecast

How is ALUR forecast to perform vs Medical Devices companies and vs the US market?

Company
-0.35%
Industry
12.58%
Market
1,518.74%
ALUR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALUR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALUR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ALUR$1.85$2.50+35.14%Hold
RBOT$2.65$7.00+164.15%Hold
HIND$2.85$15.00+426.32%Strong Buy
VVOS$2.07$6.25+201.93%Buy
ADGM$0.91$4.00+339.56%Strong Buy
View Top Medical Device Stocks

Allurion Technologies Stock Forecast FAQ

Is Allurion Technologies Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: ALUR) stock is to Hold ALUR stock.

Out of 1 analyst, 0 (0%) are recommending ALUR as a Strong Buy, 0 (0%) are recommending ALUR as a Buy, 1 (100%) are recommending ALUR as a Hold, 0 (0%) are recommending ALUR as a Sell, and 0 (0%) are recommending ALUR as a Strong Sell.

If you're new to stock investing, here's how to buy Allurion Technologies stock.

What is ALUR's earnings growth forecast for 2026-2027?

(NYSE: ALUR) Allurion Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 39.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,200.39%.

Allurion Technologies's earnings in 2026 is -$24,338,000.On average, 4 Wall Street analysts forecast ALUR's earnings for 2026 to be -$12,466,514, with the lowest ALUR earnings forecast at -$19,607,042, and the highest ALUR earnings forecast at -$4,659,081.

In 2027, ALUR is forecast to generate -$11,744,033 in earnings, with the lowest earnings forecast at -$11,282,756 and the highest earnings forecast at -$12,089,527.

What is ALUR's revenue growth forecast for 2026-2027?

(NYSE: ALUR) Allurion Technologies's forecast annual revenue growth rate of -0.35% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,518.74%.

Allurion Technologies's revenue in 2026 is $17,208,000.On average, 4 Wall Street analysts forecast ALUR's revenue for 2026 to be $158,834,825, with the lowest ALUR revenue forecast at $149,090,584, and the highest ALUR revenue forecast at $167,282,303.

In 2027, ALUR is forecast to generate $225,692,170 in revenue, with the lowest revenue forecast at $216,837,138 and the highest revenue forecast at $232,324,182.

What is ALUR's forecast return on assets (ROA) for 2026-2027?

(NYSE: ALUR) forecast ROA is -64.74%, which is lower than the forecast US Medical Devices industry average of 11.68%.

What is ALUR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ALUR price target, the average ALUR price target is $2.50, with the highest ALUR stock price forecast at $2.50 and the lowest ALUR stock price forecast at $2.50.

The Wall Street analyst predicted that Allurion Technologies's share price could reach $2.50 by Nov 20, 2026. The average Allurion Technologies stock price prediction forecasts a potential upside of 35.14% from the current ALUR share price of $1.85.

What is ALUR's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: ALUR) Allurion Technologies's current Earnings Per Share (EPS) is -$3.70. On average, analysts forecast that ALUR's EPS will be -$1.35 for 2026, with the lowest EPS forecast at -$2.12, and the highest EPS forecast at -$0.50. In 2027, ALUR's EPS is forecast to hit -$1.27 (min: -$1.22, max: -$1.31).

What is ALUR's forecast return on equity (ROE) for 2026-2027?

(NYSE: ALUR) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.